赛默飞世尔科技的争议事件
以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。
返回词条共 5 条
2021
Lacks 遗产管理方就 HeLa 细胞起诉 Thermo Fisher Scientific
提起诉讼
Henrietta Lacks 的遗产管理方起诉 Thermo Fisher Scientific，指称该公司持续商业化源自 HeLa 细胞的成果，而这些细胞是在 Lacks 不知情或未同意的情况下取得的。诉讼要求公司交出相关净利润，并请求禁止其未经遗产管理方许可使用这些细胞；这些指控并非文中所述的法院认定。
来源摘录
Lacks' cells were harvested and developed long before the advent of consent procedures used in medicine and scientific research today, but lawyers for her family say Thermo Fisher Scientific Inc., of Waltham, Massachusetts, has continued to commercialize the results well after the origins of the HeLa cell line became well known.
The estate of Henrietta Lacks sued a biotechnology company on Monday, accusing it of selling cells that doctors at Johns Hopkins Hospital took from the Black woman in 1951 without her knowledge or consent as part of "a racially unjust medical system."
The lawsuit asks the court to order Thermo Fisher Scientific to "disgorge the full amount of its net profits obtained by commercializing the HeLa cell line to the Estate of Henrietta Lacks." It also wants Thermo Fisher Scientific to be permanently enjoined from using HeLa cells without the estate's permission.
2021
2021
Henrietta Lacks遗产提起HeLa细胞诉讼
Henrietta Lacks的遗产起诉赛默飞世尔，指控其未经授权商业销售和使用HeLa细胞。该争议涉及历史上未经同意移除和商业化Lacks的细胞，以及关于生物医学利益分享和知情同意的更广泛问题。
2020
2019
停止在新疆销售及基因监控指控
赛默飞世尔宣布将停止在新疆销售设备。随后的报道和调查声称，该公司的设备及相关技术被中国安全部门用于涉及维吾尔、藏和回族人群的基因监控项目。报道后来质疑设备是否在限制下仍继续到达警察用户手中。公司还在进一步报道后停止了在西藏的DNA采集试剂盒销售。